Alagoz Selma, Trabulus Sinan
Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Division of Nephrology, Department of Internal Medicine, Istanbul University Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey.
Transplant Proc. 2019 Sep;51(7):2330-2333. doi: 10.1016/j.transproceed.2019.01.181. Epub 2019 Aug 8.
Persistence of abnormalities in mineral metabolism is common after kidney transplantation and appears to have a negative effect on survival. We aimed to evaluate the mineral metabolism and identify risk factors for persistent hyperparathyroidism (HPT) over 10 years.
We retrospectively analyzed the medical records of 176 consecutive renal transplant patients. Serum creatinine, calcium, phosphorus, and intact parathyroid hormone (iPTH) levels before and after transplantation up to the 10th year post transplantation were recorded for 11 different dates. Calcium > 10.2 mg/dL was considered hypercalcemia, phosphorus < 2.5 mg/dL was considered hypophosphatemia, and iPTH > 2.5 times the upper limit was considered HPT.
After a major fall in the first 3 months, iPTH steadily decreased over 5 years. Thereafter, it stabilized at a level of 1.5 times the upper limit. Rates of persistent HPT were 9.2% and 10.7% in the fifth and 10th years, respectively. The rate of hypercalcemia increased up to 21.7% at the ninth month, and after 10 years, it was 5.9%. The rate of hypophosphatemia peaked at 33.3% in the first month, and it was 8.9% in 10th year. Multivariate analysis revealed that calcium (P = .047) and phosphorus (P = .041) at the time of transplantation and female sex (P = .037) were independent predictors of persistent HPT in the first year. iPTH correlated significantly with kidney function and pre-transplant iPTH.
High serum levels of iPTH, calcium, and phosphorus at the time of transplantation were risk factors for persistent HPT in kidney transplant recipients, especially when renal function was suboptimal.
肾脏移植后矿物质代谢异常持续存在很常见,且似乎对生存率有负面影响。我们旨在评估矿物质代谢,并确定10年间持续性甲状旁腺功能亢进(HPT)的危险因素。
我们回顾性分析了176例连续肾移植患者的病历。记录了移植前及移植后直至第10年的11个不同时间点的血清肌酐、钙、磷和完整甲状旁腺激素(iPTH)水平。钙>10.2mg/dL被视为高钙血症,磷<2.5mg/dL被视为低磷血症,iPTH>上限的2.5倍被视为HPT。
在最初3个月大幅下降后,iPTH在5年内稳步下降。此后,它稳定在上限的1.5倍水平。持续性HPT的发生率在第5年和第10年分别为9.2%和10.7%。高钙血症的发生率在第9个月时升至21.7%,10年后为5.9%。低磷血症的发生率在第1个月时达到峰值33.3%,第10年时为8.9%。多变量分析显示,移植时的钙(P = .047)、磷(P = .041)和女性性别(P = .037)是第一年持续性HPT的独立预测因素。iPTH与肾功能和移植前iPTH显著相关。
移植时血清iPTH、钙和磷水平升高是肾移植受者持续性HPT的危险因素,尤其是当肾功能欠佳时。